Elicio Therapeutics, Inc. (ELTX)
2.98
-0.06
(-1.97%)
USD |
NASDAQ |
Aug 24, 16:00
2.98
0.00 (0.00%)
After-Hours: 20:00
Elicio Therapeutics Price to Book Value : 8.223 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 8.223 |
| August 21, 2026 | 8.389 |
| August 20, 2026 | 8.485 |
| August 19, 2026 | 8.637 |
| August 18, 2026 | 8.582 |
| August 17, 2026 | 8.334 |
| August 14, 2026 | 8.527 |
| August 13, 2026 | 8.692 |
| August 12, 2026 | 8.444 |
| August 11, 2026 | 8.361 |
| August 10, 2026 | 8.554 |
| August 07, 2026 | 8.803 |
| August 06, 2026 | 8.665 |
| August 05, 2026 | 8.803 |
| August 04, 2026 | 8.720 |
| August 03, 2026 | 7.892 |
| July 31, 2026 | 7.726 |
| July 30, 2026 | 8.03 |
| July 29, 2026 | 7.975 |
| July 28, 2026 | 8.140 |
| July 27, 2026 | 8.278 |
| July 24, 2026 | 8.278 |
| July 23, 2026 | 8.692 |
| July 22, 2026 | 8.610 |
| July 21, 2026 | 8.499 |
| Date | Value |
|---|---|
| July 20, 2026 | 8.389 |
| July 17, 2026 | 8.582 |
| July 16, 2026 | 8.830 |
| July 15, 2026 | 8.389 |
| July 14, 2026 | 8.582 |
| July 13, 2026 | 9.079 |
| July 10, 2026 | 9.603 |
| July 09, 2026 | 9.630 |
| July 08, 2026 | 9.630 |
| July 07, 2026 | 7.726 |
| July 06, 2026 | 9.092 |
| July 02, 2026 | 8.886 |
| July 01, 2026 | 14.18 |
| June 30, 2026 | 10.79 |
| June 29, 2026 | |
| June 26, 2026 | |
| June 25, 2026 | |
| June 24, 2026 | |
| June 23, 2026 | |
| June 22, 2026 | |
| June 18, 2026 | |
| June 17, 2026 | |
| June 16, 2026 | |
| June 15, 2026 | |
| June 12, 2026 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Precigen, Inc. | 58.91 |
| Agenus, Inc. | -- |
| Amgen, Inc. | 20.53 |
| Anika Therapeutics, Inc. | 2.080 |
| BioCryst Pharmaceuticals, Inc. | -- |
Price to Book Value Related Metrics
| Price | 2.98 |
| Earnings Yield | -70.93% |
| Market Cap | 65.27M |